1. Home
  2. TCI vs CLLS Comparison

TCI vs CLLS Comparison

Compare TCI & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transcontinental Realty Investors Inc.

TCI

Transcontinental Realty Investors Inc.

HOLD

Current Price

$52.73

Market Cap

380.3M

Sector

Finance

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$4.38

Market Cap

438.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCI
CLLS
Founded
1983
1999
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
380.3M
438.4M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
TCI
CLLS
Price
$52.73
$4.38
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
2.1K
54.8K
Earning Date
11-06-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
75.87
N/A
EPS
0.65
N/A
Revenue
$48,675,000.00
$82,551,000.00
Revenue This Year
N/A
$32.58
Revenue Next Year
N/A
$20.68
P/E Ratio
$81.12
N/A
Revenue Growth
N/A
129.04
52 Week Low
$25.50
$1.10
52 Week High
$59.65
$5.48

Technical Indicators

Market Signals
Indicator
TCI
CLLS
Relative Strength Index (RSI) 50.59 50.45
Support Level $49.91 $4.02
Resistance Level $53.94 $4.17
Average True Range (ATR) 1.86 0.22
MACD -0.55 -0.02
Stochastic Oscillator 34.95 51.94

Price Performance

Historical Comparison
TCI
CLLS

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: